DEVRIAZ
Live / Allowed — Third extension granted (statement of use) (as of 28 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 Sept 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98731353
- Mark type
- Word mark
- Filed
- 03 Sept 2024
- Published for opposition
- 24 Dec 2024
- Attorney of record
- Andrea Christensen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 29 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jul 2026 — SOU EXTENSION 3 GRANTED
- 28 Jul 2026 — SOU EXTENSION 3 FILED
- 28 Jul 2026 — SOU TEAS EXTENSION RECEIVED
- 30 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 30 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Jan 2026 — SOU EXTENSION 2 GRANTED
- 20 Jan 2026 — SOU EXTENSION 2 FILED
- 20 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 15 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED